Table VI. Testosterone treatment of depression.
Study | Subjects | Design | Testosterone | Antidepressant | Result |
Seidman and Rabkin, 199866 | 5 men Low testosterone levels | Open 8 weeks | 400 mg im biweekly | Yes | Marked improvement |
Seidman et al, 200167 | 32 men Hypogonadal | RCT 6 weeks | 200 mg im q-weekly | Yes | Testosterone=Placebo |
Perry et al, 200268 | 16 Older males | Open 6 weeks | 200 mg vs 100 mg qweekly | No | No dose effect Improvement late onset > early onset depression |
Pope et al, 200369 | 22 Low testosterone levels | RCT 8 weeks | Gel 1% 10 g/day | Yes | Testosterone>placebo |
Orengo et al, 200570 | 61 Hypogonadal men >50 y | RCT 12-week crossover | Gel 1% 5 g/day | Yes | Testosterone=placebo |
Seidman et al, 200571 | 26 Healthy adult men | RCT 6 weeks | im | Yes | Testosterone=placebo |
Seidman et al, 200972 | 23 Men, low testosterone Dysthymic | RCT 6 xeeks | im q 10 days | No | Testosterone>placebo |
Shores et al, 200973 | 33 Men >50 y hypogonadal Dysthymic | RCT 12 weeks | Gel 1% 7.5 g/day | Yes | Testosterone>placebo |
Pope et al, 201074 | 100 Adulte men Low testosterone levels | RCT 6 weeks | Gel 1 % | Yes | Testosterone=placebo |